Strengthening Production Capacity through the Expansion of Phosgene Derivatives and Dedicated Prototype Production Facilities
First written in FY2022. 2 of 3 entries say "Advanced", first in FY2025. Latest entry: 2026-03-27.
No other company in this theme has enough history to compare yet.
- 2026-03-27AdvancedM&A and Subsidiary Changes
「In the various phosgene derivatives markets, we have competed and worked to improve alongside this company for many years, and its technological capabilities and customer base are highly regarded.」
In addition to strengthening the existing production structure through expansion and pilot facilities for phosgene derivatives, a measure to incorporate a competitor's technological capabilities and customer base was presented. The original canonical thread remains unchanged. - FY2025AdvancedAnnual report
「Phosgene derivatives: Production capacity for ODI, a phosgene derivative used in release agents, has been expanded. A new bench-scale facility for prototype production was established to capture new demand for various phosgene derivatives.」
Specific milestones were presented for phosgene derivatives: completion of production-capacity expansion and establishment of a facility for prototype production. - FY2022First statedAnnual report
「[Productivity improvement] • Establishment of a system for increased production of dyes for aluminum coloring • Consideration and implementation of capacity expansion for phosgene derivatives • Installation of dedicated pilot-production equipment to support new product development • Cost reductions through lower unit consumption」
A productivity improvement initiative combining increased production of dyes for aluminum coloring, consideration of capacity expansion for phosgene derivatives, installation of dedicated pilot-production equipment and reductions in unit consumption was made specific for the first time.